Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 12-Feb-24 8:21 PM View:  | Zentalis Pharmaceuticals, I... (ZNTL) | 12-Feb-24 | Sale (Planned) | 1,173 | $11.44 | $13,419.10 | (< 1%) 644.45K to 643.28K | |
| 05-Feb-24 7:13 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 02-Feb-24 | Sale (Planned) | 11,552 | $11.54 | $133,310.00 | (2%) 656.0K to 644.45K | |
| 05-Feb-24 7:13 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 01-Feb-24 | Grant | 192,500 | -- | -- | 42% 463.5K to 656.0K | |
| 08-Jun-23 6:48 PM View: | Ocuphire Pharma, Inc. (OCUP) | 06-Jun-23 | Grant | 10,976 | -- | -- | 44% 24.93K to 35.9K | |
| 31-May-23 9:10 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 31-May-23 | Sale (Planned) | 27,768 | $26.27 | $729,506.00 | (6%) 491.27K to 463.5K | |
| 14-Feb-23 7:09 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 14-Feb-23 | Sale (Planned) | 8,501 | $19.96 | $169,706.00 | (2%) 499.77K to 491.27K | |
| 14-Feb-23 7:09 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 13-Feb-23 | Sale (Planned) | 3,332 | $20.42 | $68,054.10 | (< 1%) 503.1K to 499.77K | |
| 06-Feb-23 7:36 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 06-Feb-23 | Sale (Planned) | 10,000 | $22.27 | $222,678.00 | (2%) 513.1K to 503.1K | |
| 01-Feb-23 7:08 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 01-Feb-23 | Grant | 161,092 | -- | -- | 46% 352.01K to 513.1K | |
| 18-Jan-23 5:15 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 17-Jan-23 | Sale (Planned) | 10,000 | $24.15 | $241,515.00 | (3%) 362.01K to 352.01K | |
| 05-Jan-23 7:16 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 05-Jan-23 | Sale (Planned) | 10,000 | $21.02 | $210,228.00 | (3%) 372.01K to 362.01K | |
| 06-Jan-23 9:00 AM View: | Ocuphire Pharma, Inc. (OCUP) | 04-Jan-23 | Exercise (in-the money or at-the-money) | 1,574 | $0.00 | $0.16 | 7% 23.35K to 24.93K | |
| 15-Nov-22 7:50 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 15-Nov-22 | Sale (Planned) | 12,500 | $22.77 | $284,683.00 | (3%) 384.51K to 372.01K | |
| 08-Nov-22 8:38 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 08-Nov-22 | Sale (Planned) | 12,374 | $23.56 | $291,543.00 | (3%) 396.88K to 384.51K | |
| 08-Nov-22 8:38 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 07-Nov-22 | Sale (Planned) | 12,500 | $23.67 | $295,860.00 | (3%) 409.38K to 396.88K | |
| 17-Oct-22 9:02 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 17-Oct-22 | Sale (Planned) | 12,500 | $23.51 | $293,879.00 | (3%) 421.88K to 409.38K | |
| 07-Oct-22 4:40 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 06-Oct-22 | Sale (Planned) | 10,000 | $22.62 | $226,180.00 | (2%) 431.88K to 421.88K | |
| 07-Oct-22 4:40 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 05-Oct-22 | Sale (Planned) | 12,500 | $22.32 | $279,006.00 | (3%) 444.38K to 431.88K | |
| 16-Sep-22 8:25 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 16-Sep-22 | Sale (Planned) | 10,000 | $24.45 | $244,497.00 | (2%) 454.38K to 444.38K | |
| 16-Sep-22 8:25 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 15-Sep-22 | Sale (Planned) | 12,500 | $25.26 | $315,757.00 | (3%) 466.88K to 454.38K | |
| 31-May-22 4:06 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 30-May-22 | Grant | 111,072 | -- | -- | 31% 355.81K to 466.88K | |
| 05-Apr-22 6:52 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 05-Apr-22 | Sale (Planned) | 10,000 | $50.48 | $504,769.00 | (3%) 365.81K to 355.81K | |
| 16-Mar-22 5:18 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 15-Mar-22 | Sale (Planned) | 10,000 | $41.92 | $419,241.00 | (3%) 375.81K to 365.81K | |
| 08-Mar-22 7:43 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 07-Mar-22 | Sale (Planned) | 10,000 | $44.94 | $449,387.00 | (3%) 385.81K to 375.81K | |
| 15-Feb-22 6:35 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 15-Feb-22 | Sale (Planned) | 10,000 | $51.93 | $519,295.00 | (3%) 395.81K to 385.81K | |
| 14-Feb-22 9:09 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 14-Feb-22 | Sale (Planned) | 7,188 | $50.19 | $360,775.00 | (2%) 403.0K to 395.81K | |
| 14-Feb-22 9:09 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 10-Feb-22 | Grant | 15,798 | -- | -- | 4% 387.2K to 403.0K | |
| 07-Feb-22 9:53 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 07-Feb-22 | Sale (Planned) | 10,000 | $53.45 | $534,474.00 | (3%) 397.2K to 387.2K | |
| 19-Jan-22 7:21 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 18-Jan-22 | Market Sale (Planned) | 10,000 | $62.64 | $626,376.00 | (2%) 407.2K to 397.2K | (12%) |
| 05-Jan-22 5:49 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 05-Jan-22 | Market Sale (Planned) | 10,000 | $75.49 | $754,861.00 | (2%) 417.2K to 407.2K | (4%) |
| 16-Dec-21 5:18 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 15-Dec-21 | Market Sale (Planned) | 10,000 | $74.03 | $740,337.00 | (2%) 427.2K to 417.2K | (7%) |
| 07-Dec-21 8:35 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 06-Dec-21 | Market Sale (Planned) | 10,000 | $71.33 | $713,300.00 | (2%) 437.2K to 427.2K | < 1% |
| 16-Nov-21 7:11 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 15-Nov-21 | Market Sale (Planned) | 10,000 | $75.36 | $753,619.00 | (2%) 447.2K to 437.2K | (3%) |
| 05-Nov-21 9:12 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 05-Nov-21 | Market Sale (Planned) | 10,000 | $82.95 | $829,491.00 | (2%) 457.2K to 447.2K | (< 1%) |
| 04-Oct-21 9:17 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 01-Oct-21 | Market Sale (Planned) | 10,000 | $66.15 | $661,490.00 | (2%) 467.2K to 457.2K | (1%) |
| 02-Sep-21 7:32 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 01-Sep-21 | Market Sale (Planned) | 10,000 | $67.52 | $675,229.00 | (2%) 477.2K to 467.2K | < 1% |
| 03-Aug-21 7:59 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 02-Aug-21 | Market Sale (Planned) | 10,000 | $51.02 | $510,198.00 | (2%) 487.2K to 477.2K | 2% |
| 08-Jul-21 10:00 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 07-Jul-21 | Market Sale (Planned) | 2,572 | $47.13 | $121,220.00 | (< 1%) 501.95K to 499.38K | (11%) |
| 08-Jul-21 10:00 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 06-Jul-21 | Market Sale (Planned) | 15,798 | $46.88 | $740,636.00 | (3%) 503.0K to 487.2K | (12%) |
| 02-Jun-21 8:27 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 01-Jun-21 | Market Sale (Planned) | 10,000 | $54.06 | $540,551.00 | (2%) 525.57K to 515.57K | < 1% |
| 05-May-21 4:27 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 03-May-21 | Market Sale (Planned) | 10,000 | $59.25 | $592,504.00 | (2%) 535.57K to 525.57K | 5% |
| 06-Apr-21 5:48 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 06-Apr-21 | Market Sale (Planned) | 165 | $43.26 | $7,138.49 | (< 1%) 541.23K to 541.06K | < 1% |
| 06-Apr-21 5:48 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 05-Apr-21 | Market Sale (Planned) | 28,204 | $43.40 | $1,224,100.00 | (5%) 563.78K to 535.57K | < 1% |
| 03-Mar-21 4:36 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 01-Mar-21 | Market Sale (Planned) | 10,000 | $41.69 | $416,858.00 | (2%) 573.94K to 563.94K | (4%) |
| 16-Feb-21 7:01 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 11-Feb-21 | Grant | 13,750 | -- | -- | 2% 560.19K to 573.94K | |
| 03-Feb-21 5:55 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 01-Feb-21 | Market Sale (Planned) | 10,000 | $37.49 | $374,865.00 | (2%) 570.19K to 560.19K | (10%) |
| 06-Jan-21 8:25 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 04-Jan-21 | Market Sale (Planned) | 10,000 | $51.93 | $519,323.00 | (2%) 580.19K to 570.19K | (< 1%) |
| 28-Dec-20 9:01 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 24-Dec-20 | Sale (Planned) | 18,473 | -- | -- | (3%) 598.66K to 580.19K | |
| 08-Dec-20 8:38 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 08-Dec-20 | Sale (Planned) | 22,573 | $56.75 | $1,281,060.00 | (4%) 621.24K to 598.66K | |
| 08-Dec-20 8:38 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 07-Dec-20 | Sale (Planned) | 6,692 | $53.52 | $358,166.00 | (1%) 627.93K to 621.24K |